HHM Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Hold |
20
| – | – | ﹤0.01% | 604 |
|
|
2025
Q1 | $12.7K | Hold |
20
| – | – | ﹤0.01% | 565 |
|
|
2024
Q4 | $14.2K | Hold |
20
| – | – | ﹤0.01% | 544 |
|
|
2024
Q3 | $21K | Hold |
20
| – | – | ﹤0.01% | 458 |
|
|
2024
Q2 | $21K | Hold |
20
| – | – | ﹤0.01% | 442 |
|
|
2024
Q1 | $19.3K | Hold |
20
| – | – | ﹤0.01% | 417 |
|
|
2023
Q4 | $17.6K | Hold |
20
| – | – | ﹤0.01% | 424 |
|
|
2023
Q3 | $16.5K | Hold |
20
| – | – | ﹤0.01% | 432 |
|
|
2023
Q2 | $14.4K | Hold |
20
| – | – | ﹤0.01% | 463 |
|
|
2023
Q1 | $16.4K | Hold |
20
| – | – | ﹤0.01% | 444 |
|
|
2022
Q4 | $14.4K | Hold |
20
| – | – | ﹤0.01% | 402 |
|
|
2022
Q3 | $14K | Hold |
20
| – | – | ﹤0.01% | 392 |
|
|
2022
Q2 | $12K | Hold |
20
| – | – | ﹤0.01% | 507 |
|
|
2022
Q1 | $14K | Hold |
20
| – | – | ﹤0.01% | 503 |
|
|
2021
Q4 | $13K | Sell |
20
-125
| -86% | -$81.3K | ﹤0.01% | 489 |
|
|
2021
Q3 | $88K | Buy |
145
+125
| +625% | +$75.9K | 0.02% | 221 |
|
|
2021
Q2 | $11K | Hold |
20
| – | – | ﹤0.01% | 469 |
|
|
2021
Q1 | $9K | Hold |
20
| – | – | ﹤0.01% | 456 |
|
|
2020
Q4 | $10K | Buy |
+20
| New | +$10K | ﹤0.01% | 419 |
|